1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. Pyk2

Pyk2

Proline-rich tyrosine kinase 2 (Pyk2) is a cytoplasmic, non-receptor tyrosine kinase implicated in multiple signaling pathways。 It is a negative regulator of osteogenesis and considered a viable drug target for osteoporosis treatment。

Pyk2 and focal adhesion kinase (FAK) comprise the focal adhesion kinase subfamily of non-receptor tyrosine kinases. PYK2 and FAK are large multidomain proteins containing an N-terminal FERM domain, a central catalytic domain, and a C-terminal segment containing dual proline rich (PR) subdomains and a focal adhesion targeting (FAT) region.

Pyk2, a non-receptor tyrosine kinase of the FAK family, is up-regulated in more than 60% of the tumors of hepatocellular carcinoma (HCC) patients。

Pyk2 相关产品 (4):

Cat. No. Product Name Effect Purity
  • HY-10459
    PF-562271 Inhibitor 99.36%
    PF-562271 是有效,可逆,ATP竞争性的 FAKPyk2 激酶抑制剂,IC50 分别为 1.5 和 13 nM。
  • HY-10458
    PF-562271 besylate Inhibitor 98.31%
    PF-562271 besylate 是有效,可逆,ATP竞争性的 FAKPyk2 激酶抑制剂,IC50 分别为 1.5 和 13 nM。
  • HY-10460
    PF-431396 Inhibitor 99.15%
    PF-431396 is dual focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (PYK2) inhibitor (IC50 values are 2 and 11 nM respectively), PF-431396 has a Kd value of 445 nM for BRD4.
  • HY-13203
    NVP-TAE 226 Inhibitor 98.98%
    NVP-TAE 226 是一种双重酪氨酸激酶抑制剂,作用于 FAKIGF-IRIC50 分别为 5.5 nM 和 0.14 μM。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

彩票平台2元网 五百万彩票 265彩票平台 8888彩票平台 五百万彩票 新彩票平台 完美彩票 黄金彩平台 黄金彩平台 39彩票平台